首页>
外国专利>
Arthritogenic peptide, DNAJ, isolated from bacterial peptides and used in vaccine compositions for treating rheumatoid arthritis
Arthritogenic peptide, DNAJ, isolated from bacterial peptides and used in vaccine compositions for treating rheumatoid arthritis
展开▼
机译:从细菌肽中分离出来的致关节炎肽DNAJ,用于治疗类风湿关节炎的疫苗组合物中
展开▼
页面导航
摘要
著录项
相似文献
摘要
Method for the production of a vaccine composition useful in inducing T-cell mediated immune protection in a host against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis. Each vaccine composition provides antigenic dnaJp1 peptide (by including the peptide or a polynucleotide, which encodes the peptide) and, optionally, other peptide fragments of the microbial dnaJ protein and/or human homologs thereof. Also described is a method for the screening of candidates by: (i)measuring cellular and humoral immune responses to an arthritogenic peptide (ii)detecting the rheumatoid arthritis susceptibility sequence in the individual's HLA DR antigens
展开▼